Dilated cardiomyopathy in retrovirally infected mice: A novel model for silent viral DCM?

被引:5
作者
Beischel J. [1 ]
Larson D.F. [1 ,3 ]
Yu Q. [1 ,2 ]
Yang B. [1 ]
Sepúlveda R.T. [2 ]
Kelley T. [1 ]
Watson R.R. [2 ]
机构
[1] Sarver Heart Center, Tucson, AZ
[2] Arizona Prevention Center, Tucson, AZ
[3] College of Medicine, University of Arizona, Tucson
关键词
Dilated cardiomyopathy; Murine acquired immunodeficiency syndrome; Viral myocarditis;
D O I
10.1385/CT:4:4:317
中图分类号
学科分类号
摘要
Dilated cardiomyopathy (DCM) is a clinically relevant disease that can occur independently or secondary to other diseases such as HIV infection and AIDS. To study this latter process, we used a model in which mice are infected with the LP-BM5 murine AIDS (MAIDS) retrovirus. Cardiac function of control and infected mice was determined through the in vivo analysis of left ventricular pressure-volume loops. Furthermore, the role of myocarditis was investigated through immunohistochemistry for T-cell, B-cell, and macrophage cardiac infiltrates and Northern blot analysis for tumor necrosis factor (TNF)-α and inducible nitric oxide synthase (iNOS). End-systolic and end-diastolic volumes were significantly increased and ventricular stiffness was significantly decreased in infected mice, consistent with DCM; however, no staining for inflammatory cellular infiltrates or TNF-α and iNOS was seen. These data support the conclusion that the LP-BM5 HIV model virus causes DCM in the absence of chronic cardiac inflammation. These findings support MAIDS retroviral infection as a new model of idiopathic DCM in which myocarditis does not occur.
引用
收藏
页码:317 / 325
页数:8
相关论文
共 35 条
  • [1] Heart Disease and Stroke Statistics - 2003 Update, (2002)
  • [2] Towbin J.A., Bowles N.B., Genetic abnormalities responsible for dilated cardiomyopathy, Curr. Cardiol. Rep., 2, pp. 475-480, (2000)
  • [3] Bachinski L.L., Roberts R., New theories: Causes of dilated cardiomyopathy, Cardiol. Clin., 16, pp. 603-610, (1998)
  • [4] Mestroni L., Rocco C., Vatta M., Miocic S., Giacca M., Advances in molecular genetics of dilated cardiomyopathy, Cardiol. Clin., 16, pp. 611-621, (1998)
  • [5] Kearney M.T., Cotton J.M., Richardson P.J., Shah A.M., Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations, and management, Postgrad. Med. J., 77, pp. 4-10, (2001)
  • [6] Gluck B., Schmidtke M., Merkle L., Stelzner A., Gemsa D., Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice, J. Mol. Cell. Cardiol., 33, pp. 1615-1626, (2001)
  • [7] Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., Polak J.M., Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy, Lancet, 347, pp. 1151-1155, (1996)
  • [8] Lipshultz S.E., Dilated cardiomyopathy in HIV-infected patients, N. Engl. J. Med., 339, pp. 1153-1155, (1998)
  • [9] Barbara G., Lipshultz S.E., Pathogenesis of HIV-associated cardiomyopathy, Ann. NY Acad. Sci., 946, pp. 57-81, (2001)
  • [10] Fisher S.D., Lipshultz S.E., Epidemiology of cardiovascular involvement in HIV disease and AIDS, Ann. NY Acad. Sci., 946, pp. 13-22, (2001)